progressively rose from 12±4 nglml on day 0 to 705±62 ng/ml on day 10. The 25-OHD3 concentrations in normal pigs rose from 8±2 ng/ml on day 0 to 439±64 ng/ml on day 10. Plasma 25-OHD3 was higher in anephrics throughout the experiment, and concentrations were significantly higher (P < 0.05) on days 9 and 10. Plasma 24,25-(OH)2D3 concentrations declined progressively in anephric pigs from 3.6+0.6 ng/ml on day 0 to 3.2+0.7 ng/ml on day 2.
ng/ml in the plasma of eight anephric human subjects and 40.1+3.7 ng/ml in five normal human subjects. Six of the eight anephric patients had undetectable (<0.2 ng/ml) 24,25-(OH)2D concentrations. Two of the eight patients had very low (0.51 and 0.41 ng/ml), but detectable, 24,25-dihydroxyvitamin D2. The normal human volunteers had plasma 24,25-(OH)2D concentrations of 2.8±0.7 ng/ml. Chronically dialyzed anephric and normal pigs were given intramuscular injections of massive amounts (5 x 106 IU) of vitamin D3 immediately after surgery (day 0) and again on day 7 . In anephric pigs, plasma 25-OHD3 progressively rose from 12±4 nglml on day 0 to 705±62 ng/ml on day 10 . The 25-OHD3 concentrations in normal pigs rose from 8±2 ng/ml on day 0 to 439±64 ng/ml on day 10 . Plasma 25-OHD3 was higher in anephrics throughout the experiment, and concentrations were significantly higher (P < 0.05) on days 9 and 10. Plasma 24,25-(OH)2D3 concentrations declined progressively in anephric pigs from 3.6+0.6 ng/ml on day 0 to 3.2+0.7 ng/ml on day 2.
INTRODUCTION
The role of the kidney in the formation of active vitamin D3 metabolites has been shown in many laboratories (1) (2) (3) (Fig. 2) . In addition, Horst et al. (8) found material that competed in the binding assay that migrated very near the 24,25-(OH)2D region of this column. This material, designated as peak I, was five-to sixfold 2 Horst, R. L., E. T. Littledike, J. L. Riley, and J. L. Napoli.
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PLASMA (3) (4) (5) (2, 200 IU/kg ofdiet) ofvitamin D3. On the day of surgery (day 0) and again on day 7, the pigs were treated intramuscularly with 5 x 106 IU to vitamin D3. All pigs, both anephrics and controls, were subjected to peritoneal dialysis twice daily for 45 min with 500 ml of Ringer's solution that was modified to contain 5-10% dextrose. The dialysis solution was introduced and removed through a chronically implanted catheter placed in the peritoneal cavity. Blood samples from these pigs were taken frequently (as shown in Fig. 6 ).
Identity of 24,25-(OH)2D3 generated in vivo in anephric pigs. At the end of the experiment the anephric pigs were bled. The plasma lipids were extracted as described (8 The plasma 25-OHD3 concentrations in anephric anid normiial pigs are showni in Table II and Fig. 7 . All the pigs had 25-OHD3 concentrations ranging from 7 to 15 ng/ml on day 0 just before surgery. By day 1, 25-OHD3 concentrations in both anephrics and controls had risen to 50-70 ng/ml. By day 10 (3 d after the second vitamin D3 injection), the anephric pigs had significantly higher (P < 0.05) concentrations (705±62 ng/ml) of 25-OHD3 than control (439+64 ng/ml).
Plasma-Ca concentrations remained normal or slightly below (8-10 mg/dl) during days 0, 1, and 2 in both anephric and control pigs. Thereafter, a transient hypercalcemia was observed in the anephric pigs; Ca concentration (16.2 mg/dl) wvas highest on day 4. Plasma Ca was slightly elevated in normals during days [8] [9] [10] . plasma. This result is in contrast to those in previous reports (7) (8) (9) , in which detectable plasma 24,25-(OH)2D in anephric human plasma samples are described. Although none of the eight anephric patients in the present report had detectable plasma 24,25-(OH)2D3, two anephric patients (A-5 and A-7) had very low but detectable 24,25-(OH)2D2. Plasma 25-OHD2 concentrations in these two patients (10.7 and 11.7 ng/ml) were similar to those in most of the other anephric patients. The reason for the measurable 24,25-(OH)2D2 in these two patients is unknown.
Our results, therefore, confirm those of Taylor (10) Although results in early studies suggest that 1,25-(OH)2D may be adequate for treating children with vitamin D deficiency (13) , results in several other studies are in direct conflict with this concept (11, 14) . In diseases in which plasma 24,25-(OH)2D and 1,25-(OH)2D concentrations would be very low (vitamin D deficiency and renal osteodystrophy), treatment with 1,25-(OH)2D3 alone did not heal the osteomalacia associated with these diseases (11, 14 (11, 14) suggested an active role for 24,25-(OH)2D3 in normal bone formation. Although untested, response to this dual treatment might be similar in patients with renal osteodystrophy.
Another important aspect of this study is whether anephrics of any species have the ability to produce 24,25-(OH)2D in extrarenal tissues such as the intestine (15) or bone (16) . Taylor (10) (Figs. 6 and 7) . The reason for the inability of anephric pigs to 24-hydroxylate 25-OHD3 when 25-OHD3 is <400 ng/ml is unknown. One explanation may be that the Km for the 25-OHD3 of the extrarenal 24-hydroxylase might be higher than the kidney 24-hydroxylase, and thus require more substrate for hydroxylation. Alternatively, the extrarenal enzyme may require several days for activation or stimulation. The first of these hypotheses seems more likely because all patients in our study had been nephrectomized for at least 1 yr. Presumably, this would be enough time for extrarenal 24-hydroxylase stimulation. Therefore, attempting to cause an elevation in plasma 24,25-(OH)2D in anephric patients by giving exogenous vitamin D3 or 25-OHD3 might lead to toxic side effects from the high plasma concentrations of 25-OHD3 needed to satisfy the substrate concentration requirements of the extrarenal 24-hydroxylase enzyme. The hypercalcemic state of anephric pigs after vitamin D3 injections in our experiment (Table II) supports this concept.
Coniclusioni. We have conifirmeed eairlier findinigs (10) that 24,25-(OH)2D is very low to nondetectable in anephric humans consuming normal dietary levels of vitamin D. This result conflicts with results in previous work (7) (8) (9) . From our results, it is apparent that the other purification methods (7-9) for 24,25-(OH)2D determination do not adequately resolve material that will compete in the competitive protein-binding assay. We did not detect any 25,26-(OH)2D2 or 25-OHD3-26,23 lactone in normal or anephric human plasma. Apparently, therefore, other compounds (possibly peak I in Horst et al. [8] ) not related to vitamin D were measured as 24,25-(OH)2D; previous results, therefore, are erroneous. Although our system for 24, 25-(OH)2D measurement is more laborious than that of Taylor (10), it has the advantage of being able to isolate and measure other metabolites of vitamin D2 and vitamin D3.
Finally, we have shown that anephric pigs produce 24,25-(OH)2D3 when given pharmacological doses of vitamin D3 to cause superphysiological plasma 25-OHD3 concentrations of >400 nglml.
